| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5504544 | Biochemical and Biophysical Research Communications | 2017 | 7 Pages |
Abstract
Our findings suggest that PAI-1 and miR-34a, which can be clinically utilized as biomarkers for the clinical prognosis or diagnosis of NSCLC, are potential targets for the treatment of NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Xian Lin, Bing-wen Lin, Xiao-li Chen, Bei-lei Zhang, Xiong-jian Xiao, Jing-shi Shi, Jian-dong Lin, Xiao Chen,